参考文献/References:
[1] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会.等级医院评审人体器官捐献与移植技术评价标准专家共识[J].中华器官移植杂志, 2023, 44(1): 1-5.
[2] 中国肝移植注册中心, 国家肝脏移植质控中心, 国家人体捐献器官获取质控中心, et al.中国移植器官保护专家共识(2022版)[J].器官移植, 2022, 13(2): 144-160.
[3] Stewart Z A.UW solution: still the "gold standard" for liver transplantation[J].Am J Transplant, 2015, 15(2): 295-296.
[4] 徐东波, 杜智, POTTSDJ, 等.大鼠离体肝再灌注模型(IPRL)的建立及其在肝移植器官保存液实验中的意义[J].生物医学工程与临床,2001, 5(1): 3.
[5] 尹丹丹,杨沫,王运来,等.基于川芎内生枯草杆菌初步研究川芎中川芎嗪的来源[J].中国中药杂志, 2018, 43(19): 3893-3898.
[6] Liu S Y, Sylvester D M.Antithrombotic/antiplatelet activity of tetramethylpyrazine[J].Thromb Res, 1990, 58(2): 129-140.
[7] Zhou Q, Chen S, Li H, et al.Tetramethylpyrazine alleviates iron overload damage in vascular endothelium via upregulating DDAHII expression[J].Toxicol In Vitro, 2020, 65(104817).
[8] Jiang G, Xin R, Yuan W, et al.Ligustrazine ameliorates acute kidney injury through downregulation of NOD2 mediated inflammation[J].Int J Mol Med, 2020, 45(3): 731-742.
[9] Yin J, Wu J, Zhang Y, et al.Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury[J].Mol Cell Biochem, 2020, 464(1-2): 73-81.
[10] Sun W, Li A, Wang Z, et al.Tetramethylpyrazine alleviates acute kidney injury by inhibiting NLRP3/HIF?1α and apoptosis[J].Mol Med Rep, 2020, 22(4): 2655-2664.
[11] Jing L, Yao L, Zhao M, et al.Organ preservation: from the past to the future[J].Acta Pharmacol Sin, 2018, 39(5): 845-57.
[12] 陈传宝, 陈茂根, 郭义文, 等.心脏死亡器官捐献供猪腹腔多器官簇体外常温机械灌注的初步研究[J].中华移植杂志(电子版), 2021, 15(5): 257-261.
[13] Jägers J, Kirsch M, Cantore M, et al.Artificial oxygen carriers in organ preservation: Dose dependency in a rat model of ex-vivo normothermic kidney perfusion[J].Artif Organs, 2022, 46(9): 1783-1793.
[14] 孙东, 蒋欣, 赵贺, 等.低温机械灌注对扩大标准供者供肾保存效果的单中心随机对照研究[J].肾脏病与透析肾移植杂志, 2021, 30(3): 5.
[15] 高军, 刘娅玲, 王勇, 等.乳酸钠林格注射液成品的稳定性考察与分析[J].中华综合医学杂志(河北), 2003, 5(8): 2.